Clinical Trial Update: Immune Recovery in Advanced , ARV-naïve, HIV-1-infected Individuals Taking Dolutegravir or Ritonavir-boosted Darunavir [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating immune recovery in ARV-naïve HIV-1–infected individuals treated with dolutegravir or ritonavir-boosted darunavir.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome

Drugs mentioned

• Dolutegravir (dolutegravir)
• Ritonavir-boosted darunavir (darunavir boosted with ritonavir)

Snippet

Sponsor: Juan A. Arnaiz | Conditions: Acquired Immune Deficiency Syndrome Virus | Phase 4 | Status: UNKNOWN